Saad Z Usmani: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Mortality by Frailty Status as Defined by a Claims-Based Disability Status in Elderly Patients Newly Diagnosed with Multiple Myeloma in the United States

Li, Shuling, Natwick, Tanya, Liu, Jiannong, Morrison, Vicki A., Vidito, Sarah, Werther, Winifred, Mezzi, Khalid, Yusuf, Akeem, Shah, Jatin, Usmani, Saad

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 72 KB

english, 2017

52

Preliminary Results From a Phase Ib Study of Isatuximab in Combination with Pomalidomide (Pom) and Dexamethasone (Dex) in Relapsed and Refractory Multiple Myeloma (RRMM)

Richardson, Paul, Mikhael, Joseph, Usmani, Saad, Raje, Napoor, Bensinger, William, Campana, Frank, Gao, Lei, Dubin, Franck, Wack, Claudine, Anderson, Kenneth C.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 82 KB

english, 2017

53

Case Report: Deep Sustained Response to Daratumumab Associated with T-cell Expansion in a Patient with Heavily Treated Relapsed and Refractory Myeloma

Usmani, Saad, Khan, Imran, Chiu, Christopher, Foureau, David, Druhan, Lawrence, Rigby, Katherine, Casneuf, Tineke, Sasser, Kate

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 57 KB

english, 2017

54

Global, Prospective, Non-interventional, Observational Study of Disease Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma (MM) Patients (pts): The INSIGHT MM Study (NCT02761187)

Rifkin, Robert, Davies, Faith, Palumbo, Antonio, Zonder, Jeffrey A., Girnius, Saulius, Costello, Caitlin, Usmani, Saad, Berdeja, Jesus, Omel, Jim, Thompson, Michael, Schwartz, J Sanford, Hajek, Roman,

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 72 KB

english, 2017

55

Blood Transfusion Management and Transfusion-related Outcomes in Daratumumab-treated Patients With Relapsed or Refractory Multiple Myeloma

Chari, Ajai, Arinsburg, Suzanne, Jagannath, Sundar, Satta, Toshihisa, Treadwell, Ivey, Catamero, Donna, Morgan, Gillian, Feng, Huaibao, Uhlar, Clarissa, Khan, Imran, Doshi, Parul, Usmani, Saad

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 1.43 MB

english, 2017

56

Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma

Yan, Xiaoyu, Clemens, Pamela L., Puchalski, Thomas, Lonial, Sagar, Lokhorst, Henk, Voorhees, Peter M., Usmani, Saad, Richardson, Paul G., Plesner, Torben, Liu, Kevin, Orlowski, Robert Z., Losic, Nedja

Journal:

Clinical Pharmacokinetics

Year:

2017

Language:

english

File:

PDF, 866 KB

english, 2017

57

Personalized Therapy for Multiple Myeloma ||

Usmani, Saad Z., Nooka, Ajay K.

Year:

2018

Language:

english

File:

PDF, 2.10 MB

english, 2018

58

Personalized Therapy for Multiple Myeloma || Risk Stratification in Newly Diagnosed Smoldering Multiple Myeloma

Usmani, Saad Z., Nooka, Ajay K.

Year:

2018

Language:

english

File:

PDF, 234 KB

english, 2018

59

Personalized Therapy for Multiple Myeloma || Plasma Cell Leukemia

Usmani, Saad Z., Nooka, Ajay K.

Year:

2018

Language:

english

File:

PDF, 261 KB

english, 2018

60

BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations From the Organizing Committee

Holstein, Sarah A., Avet-Loiseau, Hervé, Hahn, Theresa, Ho, Christine M., Lohr, Jens G., Munshi, Nikhil C., Paiva, Bruno, Pasquini, Marcelo C., Tario, Joseph D., Usmani, Saad Z., Wallace, Paul K., Wei

Journal:

Biology of Blood and Marrow Transplantation

Year:

2017

Language:

english

File:

PDF, 918 KB

english, 2017

61

Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma

van de Donk, Niels W. C. J., Casneuf, Tineke, Di Cara, Alessandro, Parren, Paul W., Zweegman, Sonja, van Kessel, Berris, Lokhorst, Henk M., Usmani, Saad Z., Lonial, Sagar, Richardson, Paul G., Chiu, C

Journal:

British Journal of Haematology

Year:

2018

Language:

english

File:

PDF, 151 KB

english, 2018

62

Myeloid Sarcoma Presenting with Acute Renal Failure and Bilateral Ureteral Obstruction: A Case Report and Review of the Literature

Usmani, Saad Z., Shahid, Zainab, Nasser, Kamal A., Saleh, Husain

Journal:

The American Journal of the Medical Sciences

Year:

2007

Language:

english

File:

PDF, 469 KB

english, 2007

63

Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma

Chari, Ajai, Larson, Sarah, Holkova, Beata, Cornell, Robert F., Gasparetto, Cristina, Karanes, Chatchada, Matous, Jeffrey V., Niesvizky, Ruben, Valent, Jason, Lunning, Matthew, Usmani, Saad Z., Anders

Journal:

Leukemia and Lymphoma

Year:

2018

Language:

english

File:

PDF, 1.00 MB

english, 2018

64

Deep sustained response to daratumumab monotherapy associated with T-cell expansion in triple refractory myeloma

Usmani, Saad Z., Khan, Imran, Chiu, Christopher, Foureau, David, Druhan, Lawrence J., Rigby, Katherine, Casneuf, Tineke, Sasser, A. Kate

Journal:

Experimental Hematology and Oncology

Year:

2018

Language:

english

File:

PDF, 1011 KB

english, 2018

65

Characterization of the Molecular Mechanism of the Bone-Anabolic Activity of Carfilzomib in Multiple Myeloma

Hu, Bo, Chen, Yu, Usmani, Saad Z., Ye, Shiqiao, Qiang, Wei, Papanikolaou, Xenofon, Heuck, Christoph J., Yaccoby, Shmuel, Williams, Bart O., Van Rhee, Frits, Barlogie, Bart, Epstein, Joshua, Qiang, Ya-

Journal:

Year:

2013

Language:

english

File:

PDF, 2.99 MB

english, 2013

66

A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM Study

Costello, Caitlin, Boccadoro, Mario, Usmani, Saad Z., Chari, Ajai, Rifkin, Robert M., Abonour, Rafat, Berdeja, Jesus, Cook, Gordon, Goldschmidt, Hartmut, Hajek, Roman, Hungria, Vania, Lee, Hans C., Le

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2018

Language:

english

File:

PDF, 87 KB

english, 2018

67

Clinical potential of SLAMF7 antibodies – focus on elotuzumab in multiple myeloma

Friend, Reed, Bhutani, Manisha, Voorhees, Peter, Usmani, Saad

Journal:

Drug Design Development and Therapy

Year:

2017

Language:

english

File:

PDF, 420 KB

english, 2017

68

CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance

van de Donk, Niels W.C.J., Usmani, Saad Z.

Journal:

Frontiers in Immunology

Year:

2018

Language:

english

File:

PDF, 932 KB

english, 2018

69

Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma

Chari, Ajai, Lonial, Sagar, Mark, Tomer M., Krishnan, Amrita Y., Stockerl-Goldstein, Keith E., Usmani, Saad Z., Londhe, Anil, Etheredge, Delores, Fleming, Sarah, Liu, Baolian, Ukropec, Jon, Lin, Thoma

Journal:

Year:

2018

Language:

english

File:

PDF, 209 KB

english, 2018

70

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project

Usmani, Saad Z., Hoering, Antje, Cavo, Michele, Miguel, Jesus San, Goldschimdt, Hartmut, Hajek, Roman, Turesson, Ingemar, Lahuerta, Juan Jose, Attal, Michel, Barlogie, Bart, Lee, Jae Hoon, Kumar, Shaj

Journal:

Blood Cancer Journal

Year:

2018

Language:

english

File:

PDF, 660 KB

english, 2018

71

Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement

Arnall, Justin R, Usmani, Saad Z, Adamu, Hawawu, Mishkin, Joseph, Bhutani, Manisha

Journal:

Journal of Oncology Pharmacy Practice

Year:

2018

Language:

english

File:

PDF, 402 KB

english, 2018

72

High‐Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action

Adams, Homer C., Stevenaert, Frederik, Krejcik, Jakub, Van der Borght, Koen, Smets, Tina, Bald, Jaime, Abraham, Yann, Ceulemans, Hugo, Chiu, Christopher, Vanhoof, Greet, Usmani, Saad Z., Plesner, Torb

Journal:

Cytometry Part A

Year:

2018

Language:

english

File:

PDF, 1.00 MB

english, 2018

73

Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma

Hussain, M. Junaid, Robinson, Myra M., Hamadeh, Issam, Arnall, Justin, Bhutani, Manisha, Atrash, Shebli, Friend, Reed, Pineda‐Roman, Mauricio, Symanowski, James T., Usmani, Saad Z., Voorhees, Peter M.

Journal:

British Journal of Haematology

Year:

2018

Language:

english

File:

PDF, 142 KB

english, 2018

74

Higher Incidence of Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related Donor Transplantation

Copelan, Olivia, Sanikommu, Srinivasa R., Trivedi, Jigar S., Butler, Candace, Ai, Jing, Ragon, Brittany K., Jacobs, Ryan, Knight, Thomas G., Usmani, Saad Z., Grunwald, Michael R., Ghosh, Nilanjan, Sym

Journal:

Biology of Blood and Marrow Transplantation

Year:

2018

Language:

english

File:

PDF, 1.09 MB

english, 2018

75

INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma

Costello, Caitlin, Davies, Faith E, Cook, Gordon, Vela-Ojeda, Jorge, Omel, Jim, Rifkin, Robert M, Berdeja, Jesus, Puig, Noemi, Usmani, Saad Z, Weisel, Katja, Zonder, Jeffrey A, Terpos, Evangelos, Spen

Journal:

Future Oncology

Year:

2019

Language:

english

File:

PDF, 1.68 MB

english, 2019

76

A Phase Ib study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma

Mikhael, Joseph, Richardson, Paul, Usmani, Saad Z., Raje, Noopur, Bensinger, William, Karanes, Chatchada, Campana, Frank, Kanagavel, Dheepak, Dubin, Franck, Liu, Qianying, Semiond, Dorothée, Anderson,

Journal:

Year:

2019

Language:

english

File:

PDF, 333 KB

english, 2019

77

Risk Factors for 100-Day Readmission after Discharge in Allogeneic Hematopoietic Cell Transplant and Its Clinical Implications

Shahid, Zainab, He, Jiaxian, Usmani, Saad, Grunwald, Michael, Ghosh, Nilanjan, Reese, Emily, Butler, Candace, Avalos, Belinda, Copelan, Edward A.

Journal:

Biology of Blood and Marrow Transplantation

Year:

2019

Language:

english

File:

PDF, 653 KB

english, 2019

78

Induction Therapy for Newly Diagnosed Multiple Myeloma

Paul, Barry, Lipe, Brea, Ocio, Enrique M., Usmani, Saad Z.

Journal:

American Society of Clinical Oncology Educational Book

Year:

2019

Language:

english

File:

PDF, 501 KB

english, 2019

79

International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

Hillengass, Jens, Usmani, Saad, Rajkumar, S Vincent, Durie, Brian G M, Mateos, María-Victoria, Lonial, Sagar, Joao, Cristina, Anderson, Kenneth C, García-Sanz, Ramón, Serra, Eloísa Riva, Du, Juan, van

Journal:

The Lancet Oncology

Year:

2019

Language:

english

File:

PDF, 1.87 MB

english, 2019

80

Oprozomib, pomalidomide, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

Shah, Jatin, Usmani, Saad, Stadtmauer, Edward A., Rifkin, Robert M., Berenson, James R., Berdeja, Jesus G., Lyons, Roger M., Klippel, Zandra, Chang, Yu-Lin, Niesvizky, Ruben

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 1.79 MB

english, 2019

81

Subcutaneous Delivery of Daratumumab in Relapsed or Refractory Multiple Myeloma

Usmani, Saad Z., Nahi, Hareth, Mateos, Maria-Victoria, van de Donk, Niels W.C.J., Chari, Ajai, Kaufman, Jonathan L., Moreau, Philippe, Oriol, Albert, Plesner, Torben, Benboubker, Lotfi, Hellemans, Pet

Journal:

Year:

2019

Language:

english

File:

PDF, 358 KB

english, 2019

82

Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies

Mateos, Maria-Victoria, Spencer, Andrew, Nooka, Ajay K., Pour, Ludek, Weisel, Katja, Cavo, Michele, Laubach, Jacob P., Cook, Gordon, Iida, Shinsuke, Benboubker, Lotfi, Usmani, Saad Z., Yoon, Sung-Soo,

Journal:

Year:

2019

File:

PDF, 2.05 MB

2019

83

A Review of Growth Factor Support in Bloodless Autologous Hematopoietic Stem-cell Transplant

Zhao, Jennifer C., Arnall, Justin R., Martin, Allison L., Atrash, Shebli, Bhutani, Manisha, Voorhees, Peter, Avalos, Belinda, Copelan, Edward, Ghosh, Nilanjan, Hamadani, Mehdi, Usmani, Saad, Ford, Pat

Journal:

Biology of Blood and Marrow Transplantation

Year:

2019

Language:

english

File:

PDF, 677 KB

english, 2019

84

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

Usmani, Saad Zafar, Schjesvold, Fredrik, Oriol, Albert, Karlin, Lionel, Cavo, Michele, Rifkin, Robert M, Yimer, Habte Aragaw, LeBlanc, Richard, Takezako, Naoki, McCroskey, Robert Donald, Lim, Andrew B

Journal:

The Lancet Haematology

Year:

2019

Language:

english

File:

PDF, 366 KB

english, 2019

85

Multiple Myeloma: Is It Time for Biomarker-Driven Therapy?

Bhutani, Manisha, Landgren, Ola, Usmani, Saad Z.

Journal:

American Society of Clinical Oncology Educational Book

Year:

2015

Language:

english

File:

PDF, 492 KB

english, 2015

86

Extramedullary multiple myeloma

Bhutani, Manisha, Foureau, David M., Atrash, Shebli, Voorhees, Peter M., Usmani, Saad Z.

Journal:

Year:

2019

File:

PDF, 1.44 MB

2019

87

Quadruplets come of age for newly diagnosed multiple myeloma

Bhutani, Manisha, Usmani, Saad Z

Journal:

Lancet (London, England)

Year:

2019

File:

PDF, 467 KB

2019

88

Multiple Myeloma: Is It Time for Biomarker-Driven Therapy?

Bhutani, Manisha, Landgren, Ola, Usmani, Saad Z.

Journal:

American Society of Clinical Oncology Educational Book

Year:

2015

File:

PDF, 492 KB

2015

89

Isatuximab short duration fixed volume infusion combination therapy for relapsed/refractory multiple myeloma (RRMM): phase 1b feasibility/safety study

Usmani, Saad, Karanes, Chatchada, Bensinger, William I., D'Souza, Anita, Raje, Noopur, Tuchman, Sascha, Sborov, Douglas, Kanagavel, Dheepak, Dubin, Franck, Campana, Frank, Richardson, Paul G.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

File:

PDF, 68 KB

2019

90

Bone marrow Ki67 staining is prognostic for survival in newly diagnosed multiple myeloma

Atrash, Shebli, Davis, Michael, Robinson, Myra, Slaughter, Daniel, Voorhees, Peter, Usmani, Saad, Bhutani, Manisha

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

File:

PDF, 61 KB

2019

91

B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches

Shah, Nina, Chari, Ajai, Scott, Emma, Mezzi, Khalid, Usmani, Saad Z.

Journal:

Year:

2020

File:

PDF, 1.27 MB

2020

92

Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma

Chari, Ajai, Cornell, Robert F., Gasparetto, Cristina, Karanes, Chatchada, Matous, Jeffrey V., Niesvizky, Ruben, Lunning, Matthew, Usmani, Saad Z., Anderson, Larry D., Chhabra, Saurabh, Girnius, Sauli

Journal:

Hematological Oncology

Year:

2020

File:

PDF, 2.67 MB

2020

93

Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses

Xu, Xu Steven, Moreau, Philippe, Usmani, Saad Z., Lonial, Sagar, Jakubowiak, Andrzej, Oriol, Albert, Krishnan, Amrita, BladÃ©, Joan, Luo, Man, Sun, Yu-Nien, Zhou, Honghui, Nnane, Ivo, Deraedt, William

Journal:

Advances in Therapy

Year:

2020

Language:

english

File:

PDF, 666 KB

english, 2020

94

Treatment approach for young, fit, newly diagnosed multiple myeloma patients

Usmani, Saad Z., Seifter, Eric

Journal:

Hematology (American Society of Hematology)

Year:

2018

File:

PDF, 1022 KB

2018

95

Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma: Part 2 of the open-label, multicenter, dose-escalation phase 1b study (PAVO)

San-Miguel, Jesus, Usmani, Saad Z., Mateos, Maria-Victoria, van de Donk, Niels W.C.J., Kaufman, Jonathan L., Moreau, Philippe, Oriol, Albert, Plesner, Torben, Benboubker, Lotfi, Liu, Kevin, Hellemans,

Journal:

Year:

2020

File:

PDF, 1.88 MB

2020

96

Bio-Mediated Synthesis of Reduced Graphene Oxide Nanoparticles from Chenopodium album: Their Antimicrobial and Anticancer Activities

Umar, Mohammad Faisal, Ahmad, Faizan, Saeed, Haris, Usmani, Saad Ali, Owais, Mohammad, Rafatullah, Mohd

Journal:

Year:

2020

File:

PDF, 1.77 MB

2020

97

Early Mâprotein Dynamics Predicts ProgressionâFree Survival in Patients With Relapsed/Refractory Multiple Myeloma

Yan, Xiaoyu, Xu, Xu Steven, Weisel, Katja C., Mateos, MariaâVictoria, Sonneveld, Pieter, Dimopoulos, Meletios A., Usmani, Saad Zafar, Bahlis, Nizar J., Puchalski, Thomas, Ukropec, Jon, Bellew, Kevin

Journal:

Clinical and Translational Science

Year:

2020

File:

PDF, 2.16 MB

2020

98

Approaching the First Relapse after Autologous Transplant in Multiple Myeloma

Atrash, Shebli, Hamadeh, Issam, MatuszâFisher, Ashley, Ndiaye, Ami, Bhutani, Manisha, Voorhees, Peter M., Barry, Paul, Usmani, Saad Z.

Journal:

Advances in Cell and Gene Therapy

Year:

2020

File:

PDF, 14.46 MB

2020

99

Advances & Future Prospects in Newly Diagnosed Multiple Myeloma Patients

Hamadeh, Issam, Atrash, Shebli, Matusz Fisher, Ashley, Khan, Maham Ashraf, Diana Robinson, Jordan, Barry, Paul, Usmani, Saad Z.

Journal:

Advances in Cell and Gene Therapy

Year:

2020

File:

PDF, 11.00 MB

2020

100

Management of newly diagnosed transplant ineligible multiple myeloma

Atrash, Shebli, Bhutani, Manisha, Paul, Barry, Voorhees, Peter M., Usmani, Saad Z.

Journal:

Leukemia and Lymphoma

Year:

2020

File:

PDF, 1.68 MB

2020

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски